Elke Jurkiewicz

887 total citations
34 papers, 720 citations indexed

About

Elke Jurkiewicz is a scholar working on Virology, Molecular Biology and Immunology. According to data from OpenAlex, Elke Jurkiewicz has authored 34 papers receiving a total of 720 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Virology, 12 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in Elke Jurkiewicz's work include HIV Research and Treatment (14 papers), Microbial Natural Products and Biosynthesis (6 papers) and HIV/AIDS drug development and treatment (6 papers). Elke Jurkiewicz is often cited by papers focused on HIV Research and Treatment (14 papers), Microbial Natural Products and Biosynthesis (6 papers) and HIV/AIDS drug development and treatment (6 papers). Elke Jurkiewicz collaborates with scholars based in Germany, Austria and Canada. Elke Jurkiewicz's co-authors include Gerhard Hunsmann, Gerhard Höfle, Hans Reichenbach, Brigitte Kunze, Rolf Jansen, Harald Petry, Christiane Stahl‐Hennig, Ulf Dittmer, Thomas Nißlein and Wolfram Trowitzsch‐Kienast and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Journal of Virology.

In The Last Decade

Elke Jurkiewicz

34 papers receiving 703 citations

Peers

Countries citing papers authored by Elke Jurkiewicz

Since Specialization

Citations

This map shows the geographic impact of Elke Jurkiewicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elke Jurkiewicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elke Jurkiewicz more than expected).

Fields of papers citing papers by Elke Jurkiewicz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elke Jurkiewicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elke Jurkiewicz. The network helps show where Elke Jurkiewicz may publish in the future.

Co-authorship network of co-authors of Elke Jurkiewicz

This figure shows the co-authorship network connecting the top 25 collaborators of Elke Jurkiewicz. A scholar is included among the top collaborators of Elke Jurkiewicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elke Jurkiewicz. Elke Jurkiewicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risk analysis of leachables in cell and gene therapy using a CAR-T model process 2021 ·International Journal of Pharmaceutics ·(unknown), Elke Jurkiewicz	10
2	Identification and evaluation of cell- growth-inhibiting bDtBPP-analogue degradation products from phosphite antioxidants used in polyolefin bioprocessing materials 2020 ·Analytical and Bioanalytical Chemistry ·(unknown), (unknown), Elke Jurkiewicz, (unknown), Armin Hauk, (unknown), Helmar Görls, Thomas Noll, Roberto Menzel	14
3	Filtration membranes - Scavengers for leachables? 2018 ·European Journal of Pharmaceutical Sciences ·Armin Hauk, Elke Jurkiewicz, (unknown), (unknown), Roberto Menzel	14
4	Highly efficient concentration of lenti- and retroviral vector preparations by membrane adsorbers and ultrafiltration 2011 ·BMC Biotechnology ·Katrin Zimmermann, (unknown), Andreas Kocourek, (unknown), Elke Jurkiewicz, Alexander Pfeifer	41
5	Phase I/II Combined Chemoimmunotherapy with Carcinoembryonic Antigen–Derived HLA-A2–Restricted CAP-1 Peptide and Irinotecan, 5-Fluorouracil, and Leucovorin in Patients with Primary Metastatic Colorectal Cancer 2005 ·Clinical Cancer Research ·Martin R. Weihrauch, Sascha Ansén, Elke Jurkiewicz, Caroline Geisen, Zhinan Xia, Karen S. Anderson, (unknown), Manuel Schmidt, Burghardt Wittig, Volker Diehl, Juergen Wolf, Heribert Bohlen, Lee M. Nadler	54
6	Naturally Occurring V1- env Region Variants Mediate Simian Immunodeficiency Virus SIVmac Escape from High-Titer Neutralizing Antibodies Induced by a Protective Subunit Vaccine 2000 ·Journal of Virology ·Harald Petry, Katja Pekrun, Gerhard Hunsmann, Elke Jurkiewicz, Wolfgang Lüke	12
7	Prechallenge High Neutralizing Antibodies and Long-Lasting Immune Reactivity to gp41 Correlate With Protection of Rhesus Monkeys Against Productive Simian Immunodeficiency Virus Infection or Disease Development 1998 ·Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology ·Harald Petry, Ulf Dittmer, David T. Jones, Graham H. Farrar, Helmut Wächter, Dietmar Fuchs, (unknown), Elke Jurkiewicz, Gerhard Hunsmann, Christiane Stahl‐Hennig, Wolfgang Lüke	4
8	Attenuated SIV imparts immunity to challenge with pathogenic spleen-derived SIV but cannot prevent repair of the nef deletion 1996 ·Immunology Letters ·Christiane Stahl‐Hennig, Ulf Dittmer, Thomas Nißlein, Katja Pekrun, Harald Petry, Elke Jurkiewicz, (unknown), Helmut Wachter, Erling W. Rud, (unknown)	24
9	Simian Immunodeficiency Virus (SIV) gp130 Oligomers Protect Rhesus Macaques (Macaca mulatta) against the Infection with SIVmac32H Grown on T-Cells or Derivedex Vivo 1996 ·Virology ·Wolfgang Lüke, Cheick Coulibaly, Ulf Dittmer, Gérald Voss, (unknown), B. Makoschey, Ulrike Sauermann, Elke Jurkiewicz, Christiane Stahl‐Hennig, Harald Petry, Gerhard Hunsmann	19
10	Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus 1996 ·Journal of General Virology ·Christiane Stahl‐Hennig, Ulf Dittmer, Thomas Nißlein, Harald Petry, Elke Jurkiewicz, Dietmar Fuchs, (unknown), Kerstin Mätz‐Rensing, Eva Kühn, F.‐J. Kaup, Erling W. Rud, Gerhard Hunsmann	76
11	Immunization with virion-derived glycoprotein 130 from HIV-2 or SIV protects macaques against challenge virus grown in human or simian cells or prepared ex vivo. 1994 ·PubMed ·Christiane Stahl‐Hennig, Cheick Coulibaly, Harald Petry, Gérald Voss, Ulf Dittmer, Walter Bodemer, B. Makoschey, Elke Jurkiewicz, Wolfgang Lüke, Gerhard Hunsmann	7
12	Thiangazole, a new thiazoline antibiotic from Polyangium sp. (myxodacteria): Production, antimicrobial activity and mechanism of action. 1993 ·The Journal of Antibiotics ·Brigitte Kunze, Rolf Jansen, Lutz Pridzun, Elke Jurkiewicz, Gerhard Hunsmann, Gerhard Höfle, Hans Reichenbach	36
13	Chemical modifications of aminonaphthalenesulfonic acid derivatives increase effectivity and specificity of reverse transcriptase inhibition and change mode of action of reverse transcriptase and DNA polymerase alpha inhibition 1993 ·Antiviral Research ·(unknown), Elke Jurkiewicz, Wolfgang Lüke, Peter Nickel, Gerhard Hunsmann, Klaus Dieter Jentsch	1
14	Phenoxan, a new oxazole-pyrone from myxobacteria: Production, antimicrobial activity and its inhibition of the electron transport in complex I of the respiratory chain. 1992 ·The Journal of Antibiotics ·Brigitte Kunze, Rolf Jansen, Lutz Pridzun, Elke Jurkiewicz, Gerhard Hunsmann, Gerhard Höfle, Hans Reichenbach	24
15	Three New Potent HIV-1 Inhibitors from Myxobacteria 1992 ·Antiviral chemistry & chemotherapy ·Elke Jurkiewicz, Rolf Jansen, Brigitte Kunze, Wolfram Trowitzsch‐Kienast, Edgar Forche, Hans Reichenbach, Gerhard Höfle, Gerhard Hunsmann	40
16	ChemInform Abstract: Antibiotics from Gliding Bacteria. Part 45. Phenalamides, New HIV‐1 Inhibitors from Myxococcus stipitatus Mx s40. 1992 ·ChemInform ·Wolfram Trowitzsch‐Kienast, Edgar Forche, Victor Wray, Hans Reichenbach, Elke Jurkiewicz, Gerhard Hunsmann, G. HOEFLE	1
17	Neutralization of HIV-1 by anti-idiotypes to monoclonal anti-CD4. Potential for idiotype immunization against HIV 1992 ·The Journal of Immunology ·(unknown), (unknown), (unknown), Elke Jurkiewicz, G. Hunsmann, Katrin U. Lundin, I. Schedel	13
18	ChemInform Abstract: Antibiotics from Gliding Bacteria. Part 47. Thiangazole: A Novel Inhibitor of HIV‐1 from Polyangium spec. 1992 ·ChemInform ·Rolf Jansen, Brigitte Kunze, Hans Reichenbach, Elke Jurkiewicz, Gerhard Hunsmann, G. HOEFLE	1
19	Isolation and characterization of HIV-2ben obtained from a patient with predominantly neurological defects 1990 ·AIDS ·Josef Schneider, Wolfgang Lüke, Frank Kirchhoff, (unknown), Elke Jurkiewicz, Christiane Stahl‐Hennig, Sigrid Nick, E. Klemm, (unknown), Gerhard Hunsmann	20
20	In vitro anti-HIV-1 activity of chondroitin polysulphate 1989 ·AIDS ·Elke Jurkiewicz, Prasad M. Panse, (unknown), Heinz Hartmann, Gerhard Hunsmann	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact